About Siriraj Hospital; Division of Hematology, Department of Medicine
Clinical Trials at Siriraj Hospital; Division of Hematology, Department of Medicine
During the past decade, Siriraj Hospital; Division of Hematology, Department of Medicine conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 7 clinical trials were completed, i.e. on
average, 233.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Siriraj Hospital; Division of Hematology, Department of Medicine"
#1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Siriraj Hospital; Division of Hematology, Department of Medicine
According to Clinical.Site data, the most researched conditions in "Siriraj Hospital; Division of Hematology, Department of Medicine" are
"B-cell Lymphoma" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Chronic Myeloid Leukemia" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials) and "Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive" (1 trials). Many other conditions were trialed in "Siriraj Hospital; Division of Hematology, Department of Medicine" in a lesser frequency.
Clinical Trials Intervention Types at Siriraj Hospital; Division of Hematology, Department of Medicine
Most popular intervention types in "Siriraj Hospital; Division of Hematology, Department of Medicine" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (3 trials), "Rituximab" (3 trials), "CHOP" (2 trials), "Doxorubicin" (2 trials) and "Obinutuzumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Siriraj Hospital; Division of Hematology, Department of Medicine
The vast majority of trials in "Siriraj Hospital; Division of Hematology, Department of Medicine" are
9 trials for "All" genders.
Clinical Trials Status at Siriraj Hospital; Division of Hematology, Department of Medicine
Currently, there are NaN active trials in "Siriraj Hospital; Division of Hematology, Department of Medicine".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Siriraj Hospital; Division of Hematology, Department of Medicine,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Siriraj Hospital; Division of Hematology, Department of Medicine, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".